This was the stock's second consecutive day of gains.
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...